Hilal Şahin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hilal Şahin has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Ayhan Deviren
Department of Medical Biology, Faculty of Medicine, İstanbul University-Cerrahpasa, İstanbul, Türkiye
2 shared publications- Emre Tepeli
Department of Genetics, Istanbul Atlas University Faculty of Medicine, Istanbul, Turkey
2 shared publications Ersan Atahan
Department of Chest Diseases, Faculty of Medicine, İstanbul University-Cerrahpasa, İstanbul, Türkiye
2 shared publicationsMatem Tuncdemir
Department of Medical Biology, Faculty of Medicine, İstanbul University-Cerrahpasa, İstanbul, Türkiye
2 shared publicationsNail Yilmaz
Department of Histology and Embryology, Faculty of Medicine, Beykent University, İstanbul, Türkiye
2 shared publications- Oya Akça2 shared publications
Latest Publications
- 2 May 2025
- Published by Academician Publishing
- p. 119-130
Ailesel Chiari Malformasyonu
Bu bölüm, beyin dokusunun spinal kanala uzandığı serebellumun konjenital yapısal bir anomalisi olan Chiari Malformasyonu'nun (CM) kalıtımla ilgili yönlerini araştırmaktadır. CM'nin, özellikle de yetişkinlerde en sık görülen Chiari Malformasyonu Tip I (CM-I) altında yatan genetik temel, kalıtım modelleri ve moleküler mekanizmalar tartışılmaktadır. Bu bölümde ayrıca genetik sınıflandırma, tanı yöntemleri ve tüm-ekzom dizileme (WES), genom çapında ilişkilendirme çalışmaları (GWAS) ve karşılaştırmalı genomik hibridizasyon (CGH) gibi moleküler teknikler de ele alınmaktadır. CM'yi etkileyen genetik ve çevresel faktörlerin anlaşılması, erken tanı ve hedefe yönelik tedavi stratejilerini geliştirebilir. This chapter explores the inheritance related aspects of Chiari Malformation (CM), a congenital structural anomaly of the cerebellum where brain tissue extends into the spinal canal. It discusses the genetic basis, inheritance patterns, and molecular mechanisms underlying CM, particularly Chiari Malformation Type I (CM-I), the most common form in adults. The chapter also covers genetic classification, diagnostic methods, and molecular techniques such as whole-exome sequencing (WES), genome-wide association studies (GWAS), and comparative genomic hybridization (CGH). Understanding the genetic and environmental factors influencing CM can enhance early diagnosis and targeted treatment strategies.
- 2 May 2025
- Published by Academician Publishing
- p. 119-130
Ailesel Chiari Malformasyonu
Bu bölüm, beyin dokusunun spinal kanala uzandığı serebellumun konjenital yapısal bir anomalisi olan Chiari Malformasyonu'nun (CM) kalıtımla ilgili yönlerini araştırmaktadır. CM'nin, özellikle de yetişkinlerde en sık görülen Chiari Malformasyonu Tip I (CM-I) altında yatan genetik temel, kalıtım modelleri ve moleküler mekanizmalar tartışılmaktadır. Bu bölümde ayrıca genetik sınıflandırma, tanı yöntemleri ve tüm-ekzom dizileme (WES), genom çapında ilişkilendirme çalışmaları (GWAS) ve karşılaştırmalı genomik hibridizasyon (CGH) gibi moleküler teknikler de ele alınmaktadır. CM'yi etkileyen genetik ve çevresel faktörlerin anlaşılması, erken tanı ve hedefe yönelik tedavi stratejilerini geliştirebilir. This chapter explores the inheritance related aspects of Chiari Malformation (CM), a congenital structural anomaly of the cerebellum where brain tissue extends into the spinal canal. It discusses the genetic basis, inheritance patterns, and molecular mechanisms underlying CM, particularly Chiari Malformation Type I (CM-I), the most common form in adults. The chapter also covers genetic classification, diagnostic methods, and molecular techniques such as whole-exome sequencing (WES), genome-wide association studies (GWAS), and comparative genomic hybridization (CGH). Understanding the genetic and environmental factors influencing CM can enhance early diagnosis and targeted treatment strategies.
- Open Access
- 2 May 2025
- Published by Academician Publishing
Chiari Malformasyonları
Chiari Malformasyonu Tarihçesi, Sınıflandırmaları Hidayet AKDEMİR Chiari Malformasyonları Bağlantılı Doku ve Organların Embriyonal Gelişim Süreçleri Ayhan BİLİR Posterior Fossa ve Kraniyovertebral Anatomi Ahmet KALAYCIOĞLU Nureda NALÇACI BOZKURT Chiari Malformasyonlarında Klinik Semptom ve Bulgular, Ayırıcı Tanı ve Klinik Testler Ali Osman MUÇUOĞLU Chiari Malformasyonlarının Radyolojik Tarihçesi ve Güncel Volumetrik Yaklaşımlar Niyazi ACER Mustafa TAŞTAN Chiari Malformasyonları Elektrofizyoloji Demet AYGÜN ÜSTEL Ailesel Chiari Malformasyonu Oya AKÇA Hilal ŞAHİN Emre TEPELİ Pediatrik Chiari Malformasyonları Nazlı ÇAKICI ÖKSÜZ Chiari Malformasyonunda Epidemiyoloji, Konservatif Tedaviler ve Gebelikte Hasta Yönetimi Meltem CAN İKE Chiari Malformasyonları Cerrahi Tedavisinin Tarihçesi ve Güncel Yaklaşımlar Hidayet AKDEMİR Chiari Tip I Malformasyonunda Dural Dış Tabakanın Alınması ile Dekompresyon Rahmi Kemal KOÇ Halil ULUTABANCA Chiari Malformasyonları ve Baziller İnvaginasyon Ebubekir AKPINAR İlhan YILMAZ Chiari Malformasyonu ve Siringomiyeli Hidayet AKDEMİR Chiari Malformasyonu Cerrahisinin Komplikasyonları Hüseyin DOĞU Chiari Malformasyonu: Aile Rehberi Hidayet AKDEMİR
- 2 May 2025
- Published by Academician Publishing
Open AccessChiari Malformasyonları
Chiari Malformasyonu Tarihçesi, Sınıflandırmaları Hidayet AKDEMİR Chiari Malformasyonları Bağlantılı Doku ve Organların Embriyonal Gelişim Süreçleri Ayhan BİLİR Posterior Fossa ve Kraniyovertebral Anatomi Ahmet KALAYCIOĞLU Nureda NALÇACI BOZKURT Chiari Malformasyonlarında Klinik Semptom ve Bulgular, Ayırıcı Tanı ve Klinik Testler Ali Osman MUÇUOĞLU Chiari Malformasyonlarının Radyolojik Tarihçesi ve Güncel Volumetrik Yaklaşımlar Niyazi ACER Mustafa TAŞTAN Chiari Malformasyonları Elektrofizyoloji Demet AYGÜN ÜSTEL Ailesel Chiari Malformasyonu Oya AKÇA Hilal ŞAHİN Emre TEPELİ Pediatrik Chiari Malformasyonları Nazlı ÇAKICI ÖKSÜZ Chiari Malformasyonunda Epidemiyoloji, Konservatif Tedaviler ve Gebelikte Hasta Yönetimi Meltem CAN İKE Chiari Malformasyonları Cerrahi Tedavisinin Tarihçesi ve Güncel Yaklaşımlar Hidayet AKDEMİR Chiari Tip I Malformasyonunda Dural Dış Tabakanın Alınması ile Dekompresyon Rahmi Kemal KOÇ Halil ULUTABANCA Chiari Malformasyonları ve Baziller İnvaginasyon Ebubekir AKPINAR İlhan YILMAZ Chiari Malformasyonu ve Siringomiyeli Hidayet AKDEMİR Chiari Malformasyonu Cerrahisinin Komplikasyonları Hüseyin DOĞU Chiari Malformasyonu: Aile Rehberi Hidayet AKDEMİR
- 1 January 2024
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 15 (1) , 11-15
Alterations in expression of phosphatase and tensin homologous (PTEN) gene analyzed in the bronchial lavage samples of non-small cell lung cancer patients
Aim In this study, we aimed to analyze the expression of the Phosphatase and Tensin Homologous gene (PTEN) by interphase-fluorescence in situ-hybridization (iFISH), and localization and immunoreactivity of PTEN by immunocytochemistry method in bronchoalveolar lavage (BAL) fluid of patients with non-small cell lung cancer (NSCLC). Methods BAL samples collected from 30 patients diagnosed with NSCLC and from 10 control subjects without any malignancy were included. iFISH was performed with a 10q23.3 PTEN DNA dual color FISH probe, analyzing multiple cells. Immunocytochemistry was based on the Streptavidin-Biotin-Peroxidase method and PTEN levels were semi-quantitatively scored. Results The percentage of cells with 2G/2R was 86.8% which was significantly lower than that of the control group (P < .001). Loss of the PTEN gene was 6.43% among all patients. The percentage of cells with monoallelic deletion (P = .0246) and atypical signal (P = .001) and the percentage of monosomic cells (P = .001) were significantly higher in patients compared to controls. PTEN immunopositivity was significantly increased in patients compared to controls (P < .001). Conclusion Increased abnormal signals and mutational cells in BAL samples of NSCLC patients suggest that the investigation of the PTEN gene in BAL by using iFISH may guide clinicians in differential diagnosis and therapeutic management of NSCLC. Being faster, easier and cost-effective in routine testing, the immunocytochemistry method can also be combined as a diagnostic tool with molecular methods.
- 1 January 2024
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 15 (1) , 11-15
Alterations in expression of phosphatase and tensin homologous (PTEN) gene analyzed in the bronchial lavage samples of non-small cell lung cancer patients
Aim In this study, we aimed to analyze the expression of the Phosphatase and Tensin Homologous gene (PTEN) by interphase-fluorescence in situ-hybridization (iFISH), and localization and immunoreactivity of PTEN by immunocytochemistry method in bronchoalveolar lavage (BAL) fluid of patients with non-small cell lung cancer (NSCLC). Methods BAL samples collected from 30 patients diagnosed with NSCLC and from 10 control subjects without any malignancy were included. iFISH was performed with a 10q23.3 PTEN DNA dual color FISH probe, analyzing multiple cells. Immunocytochemistry was based on the Streptavidin-Biotin-Peroxidase method and PTEN levels were semi-quantitatively scored. Results The percentage of cells with 2G/2R was 86.8% which was significantly lower than that of the control group (P < .001). Loss of the PTEN gene was 6.43% among all patients. The percentage of cells with monoallelic deletion (P = .0246) and atypical signal (P = .001) and the percentage of monosomic cells (P = .001) were significantly higher in patients compared to controls. PTEN immunopositivity was significantly increased in patients compared to controls (P < .001). Conclusion Increased abnormal signals and mutational cells in BAL samples of NSCLC patients suggest that the investigation of the PTEN gene in BAL by using iFISH may guide clinicians in differential diagnosis and therapeutic management of NSCLC. Being faster, easier and cost-effective in routine testing, the immunocytochemistry method can also be combined as a diagnostic tool with molecular methods.
- Open Access
- 23 March 2023
- Published by Özgür Yayınları
- p. 125-136
Hematolojik Malignitelerde Sitogenetiğin Tanısal ve Terapötik Yönleri
Cancer is one of the most common and feared diseases of modern society. In recent years, its incidence has been gradually increasing. Studies have concentrated on targeted therapy as a result of the understanding of the molecular characteristics of cancer. The aim of this book is to analyze the literature on new targeted therapeutic approaches to cancers. This book covers areas such as basic science, cancer-specific molecular approaches and signaling pathway, targeted drugs, clinical trials and psychotherapy. Cancer, or multiple stress responses, underlie many human, animal, and plant diseases, and this is an important component of our book content. The range of topics of this book will have a great deal of relevance as cancer-related diseases progress rapidly in the world's environment. Kanser, modern toplumun en yaygın ve korkulan hastalıklarından biridir. Son yıllarda insidansı giderek artmaktadır. Kanserin moleküler özelliklerinin anlaşılmaya başlamasıyla birlikte çalışmalar hedefe yönelik tedaviler üzerine yoğunlaşmıştır. Bu kitabın amacı ise kanserlere yeni hedefli terapötik yaklaşimlara ilişkin literatürü analiz etmektir. Bu kitap temel bilim, kanserlere özgü moleküler yaklaşımlar ve sinyal yolakları, hedefli ilaçlar, klinik araştırmalar ve psikoterapi gibi alanları kapsamaktadır. Kanser veya çoklu stres tepkileri birçok insan, hayvan ve bitki hastalığının altında yatmaktadır ve bu da kitap içeriğimizin önemli bir bileşenini oluşturmaktadır. Bu kitabın konu yelpazesi, kanserle ilişkili hastalıklar dünya çapında hızla ilerledikçe büyük bir güncelliğe sahip olacaktır.
- 23 March 2023
- Published by Özgür Yayınları
- p. 125-136
Open AccessHematolojik Malignitelerde Sitogenetiğin Tanısal ve Terapötik Yönleri
Cancer is one of the most common and feared diseases of modern society. In recent years, its incidence has been gradually increasing. Studies have concentrated on targeted therapy as a result of the understanding of the molecular characteristics of cancer. The aim of this book is to analyze the literature on new targeted therapeutic approaches to cancers. This book covers areas such as basic science, cancer-specific molecular approaches and signaling pathway, targeted drugs, clinical trials and psychotherapy. Cancer, or multiple stress responses, underlie many human, animal, and plant diseases, and this is an important component of our book content. The range of topics of this book will have a great deal of relevance as cancer-related diseases progress rapidly in the world's environment. Kanser, modern toplumun en yaygın ve korkulan hastalıklarından biridir. Son yıllarda insidansı giderek artmaktadır. Kanserin moleküler özelliklerinin anlaşılmaya başlamasıyla birlikte çalışmalar hedefe yönelik tedaviler üzerine yoğunlaşmıştır. Bu kitabın amacı ise kanserlere yeni hedefli terapötik yaklaşimlara ilişkin literatürü analiz etmektir. Bu kitap temel bilim, kanserlere özgü moleküler yaklaşımlar ve sinyal yolakları, hedefli ilaçlar, klinik araştırmalar ve psikoterapi gibi alanları kapsamaktadır. Kanser veya çoklu stres tepkileri birçok insan, hayvan ve bitki hastalığının altında yatmaktadır ve bu da kitap içeriğimizin önemli bir bileşenini oluşturmaktadır. Bu kitabın konu yelpazesi, kanserle ilişkili hastalıklar dünya çapında hızla ilerledikçe büyük bir güncelliğe sahip olacaktır.
- Open Access
- 22 June 2022
- Published by Springer Nature in Research Square
Alterations in Expression of Phosphatase and Tensin Homologous (Pten) Gene Analyzed in the Bronchial Lavage Samples of Non-small Cell Lung Cancer Patients
Objective: The aim was to analyze the expression of Phosphatase and Tensin Homologous gene (PTEN) gene by interphase fluorescence in situ hybridization (iFISH), and localization and immunoreactivity of PTEN by immunocytochemistry method in bronchoalveolar lavage (BAL) fluid of patients with non-small cell lung cancer (NSCLC).Methods: BAL samples collected from 30 patients diagnosed with NSCLC and from 10 control subjects without any malignancy were included. iFISH was performed with 10q23.3 PTEN DNA dual color FISH probe, analyzing multiple cells including normal cell (2G2R), biallelic deleted cell (2G), monoallelic deleted cell (2G1R), monosomic cell (1G1R) and atypical signals. Immunocytochemistry was based on Streptavidin-Biotin-Peroxidase method and PTEN levels were semi-quantitatively scored.Results: Percentage of cells with 2G/2R was 86.8% which was , significantly lower than that of control group (p<0.0001). Loss of PTEN gene was 6.43% among all patients. The Percentage of cells with monoallelic deletion (p=0.0246) and atypical signal (p=0.0001) and percentage of monosomic cells (p=0.0001) were significantly higher in patients compared to controls. PTEN immunopositivity was significantly increased in patients compared to controls (p<0.0001).Conclusion: The signal characteristics of cells can alter among NSCLC patients. The increased abnormal signals and mutational cells in BAL samples of NSCLC patients suggest that the investigation of PTEN expression in BAL by using molecular cytogenetic methods may guide the clinicians in differential diagnosis and therapeutic management of NSCLC. Being faster, easier, and cost-effective in routine testing, immunocytochemistry method can also be combined as a diagnostic tool with molecular methods.
- 22 June 2022
- Published by Springer Nature in Research Square
Open AccessAlterations in Expression of Phosphatase and Tensin Homologous (Pten) Gene Analyzed in the Bronchial Lavage Samples of Non-small Cell Lung Cancer Patients
Objective: The aim was to analyze the expression of Phosphatase and Tensin Homologous gene (PTEN) gene by interphase fluorescence in situ hybridization (iFISH), and localization and immunoreactivity of PTEN by immunocytochemistry method in bronchoalveolar lavage (BAL) fluid of patients with non-small cell lung cancer (NSCLC).Methods: BAL samples collected from 30 patients diagnosed with NSCLC and from 10 control subjects without any malignancy were included. iFISH was performed with 10q23.3 PTEN DNA dual color FISH probe, analyzing multiple cells including normal cell (2G2R), biallelic deleted cell (2G), monoallelic deleted cell (2G1R), monosomic cell (1G1R) and atypical signals. Immunocytochemistry was based on Streptavidin-Biotin-Peroxidase method and PTEN levels were semi-quantitatively scored.Results: Percentage of cells with 2G/2R was 86.8% which was , significantly lower than that of control group (p<0.0001). Loss of PTEN gene was 6.43% among all patients. The Percentage of cells with monoallelic deletion (p=0.0246) and atypical signal (p=0.0001) and percentage of monosomic cells (p=0.0001) were significantly higher in patients compared to controls. PTEN immunopositivity was significantly increased in patients compared to controls (p<0.0001).Conclusion: The signal characteristics of cells can alter among NSCLC patients. The increased abnormal signals and mutational cells in BAL samples of NSCLC patients suggest that the investigation of PTEN expression in BAL by using molecular cytogenetic methods may guide the clinicians in differential diagnosis and therapeutic management of NSCLC. Being faster, easier, and cost-effective in routine testing, immunocytochemistry method can also be combined as a diagnostic tool with molecular methods.